| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael Amoroso | President and CEO | 2025-11-03 | 3,409 | $6.49 | $22.12kSell |
| Dario Scimeca | General Counsel and Secretary | 2025-11-03 | 665 | $6.49 | $4.32kSell |
| John Alexander Kelly | Chief Financial Officer | 2025-11-03 | 1,303 | $6.49 | $8.46kSell |
| Stanley Frankel | Director | 2025-09-26 | 2,700 | $4.97 | $13.42kBuy |
| Melinda Brown | Director | 2025-09-22 | 1,400 | $4.89 | $6.85kBuy |
| John Alexander Kelly | Chief Financial Officer | 2025-07-03 | 14,827 | $4.26 | $63.16kSell |
| Melinda Brown | Director | 2025-06-25 | 1,682 | $4.14 | $6.96kBuy |
| Kevin Buehler | Director | 2025-06-25 | 5,076 | $4.16 | $21.12kBuy |
| Melinda Brown | Director | 2025-03-26 | 1,839 | $4.75 | $8.74kBuy |
| Kevin Buehler | Director | 2025-03-26 | 4,523 | $4.67 | $21.12kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Pharma Ag Novartis | 93.59% | 12,407,440 | $62.29M | Insider |
| Venbio Global Strategic Fund LP | 32.17% | 4,265,141 | $21.41M | Insider |
| Derek Jantz | 30.59% | 4,055,174 | $20.36M | Insider |
| Fmr LLC | 28.20% | 3,738,248 | $18.77M | Insider |
| Matthew R. Kane | 15.27% | 2,024,438 | $10.16M | Insider |
| Bleichroeder LP | 8.11% | 1,075,000 | $5.40M | Institution |
| Lynx1 Capital Management LP | 7.86% | 1,042,596 | $5.23M | Institution |
| Tang Capital Management LLC | 4.93% | 653,649 | $3.28M | Institution |
| Vanguard Group Inc | 3.72% | 492,596 | $2.47M | Institution |
| Renaissance Technologies LLC | 1.48% | 196,177 | $984.81k | Institution |